| Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study P Musicha, JE Cornick, N Bar-Zeev, N French, C Masesa, B Denis, ... The Lancet infectious diseases 17 (10), 1042-1052, 2017 | 280 | 2017 |
| Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa J Hakim, V Musiime, AJ Szubert, J Mallewa, A Siika, C Agutu, S Walker, ... New England Journal of Medicine 377 (3), 233-245, 2017 | 193 | 2017 |
| Evaluation of antiretroviral therapy results in a resource‐poor setting in Blantyre, Malawi JJ Van Oosterhout, N Bodasing, JJ Kumwenda, C Nyirenda, J Mallewa, ... Tropical Medicine & International Health 10 (5), 464-470, 2005 | 178 | 2005 |
| Rapid Emergence of Multidrug Resistant, H58-Lineage Salmonella Typhi in Blantyre, Malawi NA Feasey, K Gaskell, V Wong, C Msefula, G Selemani, S Kumwenda, ... PLoS neglected tropical diseases 9 (4), e0003748, 2015 | 153 | 2015 |
| HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options JE Mallewa, E Wilkins, J Vilar, M Mallewa, D Doran, D Back, ... Journal of Antimicrobial Chemotherapy 62 (4), 648-660, 2008 | 138 | 2008 |
| High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi MG Chibwana, KC Jere, R Kamn’gona, J Mandolo, V Katunga-Phiri, ... medrxiv, 2020 | 132 | 2020 |
| The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated services OH Divala, A Amberbir, Z Ismail, T Beyene, D Garone, C Pfaff, V Singano, ... BMC public health 16, 1-11, 2016 | 120 | 2016 |
| Three Epidemics of Invasive Multidrug-Resistant Salmonella Bloodstream Infection in Blantyre, Malawi, 1998–2014 NA Feasey, C Masesa, C Jassi, EB Faragher, J Mallewa, M Mallewa, ... Clinical Infectious Diseases 61 (suppl_4), S363-S371, 2015 | 100 | 2015 |
| Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within … NI Paton, C Kityo, J Thompson, I Nankya, L Bagenda, A Hoppe, J Hakim, ... The lancet HIV 4 (8), e341-e348, 2017 | 79 | 2017 |
| Lumbar puncture refusal in sub-Saharan Africa: a call for further understanding and intervention KT Thakur, K Mateyo, L Hachaambwa, V Kayamba, M Mallewa, J Mallewa, ... Neurology 84 (19), 1988-1990, 2015 | 77 | 2015 |
| Mathematical modeling to assess the drivers of the recent emergence of typhoid fever in Blantyre, Malawi VE Pitzer, NA Feasey, C Msefula, J Mallewa, N Kennedy, Q Dube, ... Clinical Infectious Diseases 61 (suppl_4), S251-S258, 2015 | 73 | 2015 |
| Etiology and risk factors for mortality in an adult community-acquired pneumonia cohort in Malawi SJ Aston, A Ho, H Jary, J Huwa, T Mitchell, S Ibitoye, S Greenwood, ... American journal of respiratory and critical care medicine 200 (3), 359-369, 2019 | 71 | 2019 |
| Stavudine toxicity in adult longer-term ART patients in Blantyre, Malawi JJ van Oosterhout, J Mallewa, S Kaunda, N Chagoma, Y Njalale, ... Public Library of Science 7 (7), e42029, 2012 | 65 | 2012 |
| Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up … JG Hakim, J Thompson, C Kityo, A Hoppe, A Kambugu, JJ van Oosterhout, ... The Lancet Infectious Diseases 18 (1), 47-57, 2018 | 49 | 2018 |
| Late presentation with HIV in Africa: phenotypes, risk, and risk stratification in the REALITY trial A Siika, L McCabe, M Bwakura-Dangarembizi, C Kityo, J Mallewa, ... Clinical Infectious Diseases 66 (suppl_2), S140-S146, 2018 | 40 | 2018 |
| Sustained reduction in third-generation cephalosporin usage in adult inpatients following introduction of an antimicrobial stewardship program in a large, urban hospital in Malawi R Lester, K Haigh, A Wood, EE MacPherson, H Maheswaran, P Bogue, ... Clinical Infectious Diseases 71 (9), e478-e486, 2020 | 39 | 2020 |
| Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre … N Bar-Zeev, TD Swarthout, DB Everett, M Alaerts, J Msefula, C Brown, ... The Lancet Global Health 9 (7), e989-e998, 2021 | 37 | 2021 |
| Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial FA Post, AJ Szubert, AJ Prendergast, V Johnston, H Lyall, F Fitzgerald, ... Clinical infectious diseases 66 (suppl_2), S132-S139, 2018 | 34 | 2018 |
| Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa B Morton, KG Barnes, C Anscombe, K Jere, P Matambo, J Mandolo, ... Nature communications 12 (1), 3554, 2021 | 27 | 2021 |
| Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open … J Mallewa, AJ Szubert, P Mugyenyi, E Chidziva, MJ Thomason, ... The lancet HIV 5 (5), e231-e240, 2018 | 27 | 2018 |
